SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-132064

Patient #032

Tay Shu Hui · 55y · Female · Chinese · BMI 29.1 · ECOG 0
SMCAS - Sunway Medical Centre AS · Medical Oncology · Dr. Chong Boon Keat
IIIA (T2a, N2)Disease-free
No mutations
Clinical storyline

Tay Shu Hui, a 55-year-old Chinese female (never, ECOG 0), presented in 2023-02 with unintentional weight loss (~5kg over 3 months). Workup confirmed Adenocarcinoma (Stage III). The MDT recommended platinum-based chemo-immunotherapy. Current status: Disease-free.

HPE Results
Moderately differentiated adenocarcinoma, stage IIIA (T2b, N2, Mx), no mutations (2x testing)
Clinical Stage
IIIA (T2a, N2)
Pathological Stage
IIIA (T2b, N2, Mx)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
380
Tumor (CT/PET)
3.7 cm
PET SUV
8.17
NGS Results
No mutations detected